汇群中药 (832513.OC)

+ 收藏

利润表(汇群中药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
一、营业总收入(元) 496,759,064.88244,653,993.02436,595,895.17205,922,110.30
 营业收入(元) 496,759,064.88244,653,993.02436,595,895.17205,922,110.30
二、营业总成本(元) 445,997,220.07214,525,293.13395,566,154.16187,415,106.59
 营业成本(元) 388,816,806.39188,058,128.63335,668,855.62158,708,273.46
 研发费用(元) 11,149,463.005,226,957.6911,395,038.064,689,730.75
 营业税金及附加(元) 2,175,083.201,140,823.892,288,665.301,179,468.66
 销售费用(元) 18,315,305.109,522,245.6617,692,635.378,043,566.00
 管理费用(元) 24,101,482.5010,051,429.3326,245,250.4013,440,687.77
 财务费用(元) 1,439,079.88525,707.932,275,709.411,353,379.95
  其中:利息费用(元) 1,663,926.28722,838.632,128,278.071,205,726.53
  其中:利息收入(元) 578,195.90366,736.99292,957.52110,282.99
三、其他经营收益
 资产处置收益(元) -13,835.40-13,767.49--
 资产减值损失(元) -1,757,412.94-1,431,976.28-676,207.96-379,272.75
 信用减值损失(元) -98,405.37491,779.38-440,770.58-178,480.54
 其他收益(元) 1,364,523.19243,895.73205,185.12149,143.20
四、营业利润(元) 50,256,714.2929,418,631.2340,117,947.5918,098,393.62
 减:营业外支出(元) 90,208.5112,757.89204,253.06165,903.98
五、利润总额(元) 50,166,505.7829,405,873.3439,913,694.5317,932,489.64
 减:所得税费用(元) 1,180,162.531,329,204.101,120,961.30789,017.45
六、净利润(元) 48,986,343.2528,076,669.2438,792,733.2317,143,472.19
(一)按经营持续性分类
  持续经营净利润(元) 48,986,343.2528,076,669.2438,792,733.2317,143,472.19
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 48,986,343.2528,076,669.2438,792,733.2317,143,472.19
 扣除非经常性损益后的净利润(元) 48,450,878.4627,884,840.4338,972,291.2317,332,807.31
七、每股收益
 一、基本每股收益(元) 1.010.580.800.35
九、综合收益总额(元) 48,986,343.2528,076,669.2438,792,733.2317,143,472.19
 归属于母公司所有者的综合收益总额(元) 48,986,343.2528,076,669.2438,792,733.2317,143,472.19
公告日期 2024-04-122023-08-222023-03-102022-08-01
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院